Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas

Wen-Ting Cheng1 School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, Republic of China

Hsiu-O Ho1 School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, Republic of China

https://orcid.org/0000-0002-4585-6289

Shyr-Yi Lin2 Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, Republic of China;3 Department of General Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, Republic of China

Der-Zen Liu4 Graduate Institute of Biomedical Materials and Engineering, Taipei Medical University, Taipei, Taiwan, Republic of China

Ling-Chun Chen5 Department of Biotechnology and Pharmaceutical Technology, Yuanpei University of Medical Technology, Hsinchu, Taiwan, Republic of ChinaCorrespondence[email protected]

Ming-Thau Sheu1 School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan, Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0003-1995-8369

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas

Articles from other publishers (5)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas

Citations (5)

Articles from other publishers (5)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date